Pricing Log in Create free account

Legend Biotech Corporation Sponsored ADR (LEGN) vs Relay Therapeutics, Inc. (RLAY)

Legend Biotech Corporation Sponsored ADR and Relay Therapeutics, Inc. are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR is the larger, with a market value of $4.4B against $3.7B — 1.2× the size. Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against −74.3%. Relay Therapeutics, Inc. has the higher net margin (0.00% vs −7.20%) and the higher return on invested capital (0.00% vs −9.54%). Across the 18 metrics below, Legend Biotech Corporation Sponsored ADR leads on 9 and Relay Therapeutics, Inc. on 9.

Valuation

Metric LEGN RLAY Biotechnology median
P/E n/m n/m 10.60
P/S 3.45 366.52 9.40
P/B 3.57 4.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.95 289.55 9.02
Earnings yield (2.11%) (8.20%) (32.88%)
Free cash flow yield (2.79%) (5.31%) (23.13%)

Profitability

Metric LEGN RLAY Biotechnology median
Gross margin 56.58% 100.00% 68.51%
Operating margin (5.06%) 0.00% 0.00%
Net margin (7.20%) 0.00% 0.00%
Free cash flow margin (9.58%) 0.00% 0.00%
Return on equity (8.08%) (41.16%) (51.96%)
Return on assets (5.32%) (37.37%) (46.06%)
Return on invested capital (9.54%) 0.00% 0.00%

Growth

Metric LEGN RLAY Biotechnology median
Revenue growth (TTM) 59.55% (74.29%) 6.76%
EPS growth (last fiscal year) (66.34%) 31.78% 29.88%
Revenue growth, 5-year CAGR 65.93% (28.58%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEGN RLAY Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 3.04 14.62 4.97
Net debt to EBITDA 2.31 1.84 1.01

Dividend

Metric LEGN RLAY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LEGN RLAY Biotechnology median
Market cap 4.37b 3.73b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack